On-line CME Education Discusses Lymphoma. Today, Hodgkin’s disease is curable in most patients with a 5-year survival rate of 86%. But this is only one type of lymphoma and as we’ll see today, hematologists have made enormous strides in the management of all types of lymphoma. Joining our moderator are two lymphoma experts from The Ohio State University and the James Cancer Hospital. Dr. Kami Maddocks is an Associate Professor of Internal Medicine from the Division of Hematology. And Dr. Beth Christian is also a hematologist and Associate Professor of Internal Medicine.
View a video introduction of this webcast
What you’ll learn in this webcast
As a result of this educational activity, webcast participants will be able to: DEFINE the most common types of aggressive lymphomas, identify both urgent initial presentations and urgent complications of treatment, and outline standards of survivorship; and DESCRIBE the features of indolent non-Hodgkin lymphoma including the most common subtypes, follicular lymphoma, marginal zone lymphoma and Waldenström macroglobulinemia.
You’ll also learn about the following:
- What causes lymphoma
- The spectrum of lymphomas
- Stem cell transplant in aggressive lymphomas
- Whether there a role for “maintenance rituximab”
- Chronic lymphocytic leukemia versus non-Hodgkin lymphoma
- Lymphoma mimics
- Deciding when to biopsy an enlarged lymph node
You can find this and many other MedNet21 programs on the OSU – CCME website.
Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at email@example.com.